Report Thumbnail
Product Code IM0912207489QO
Published Date 2024/3/2
English141 PagesGlobal

Medical Thawing System Market Report by Product Type (Manual, Automated), Sample Type (Blood, Embryo, Ovum, Semen), End User (Blood Banks, Hospitals, Tissue Banks, Pharmaceutical and Biotech Companies, and Others), and Region 2024-2032Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code IM0912207489QO◆The Mar 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/3/2
English 141 PagesGlobal

Medical Thawing System Market Report by Product Type (Manual, Automated), Sample Type (Blood, Embryo, Ovum, Semen), End User (Blood Banks, Hospitals, Tissue Banks, Pharmaceutical and Biotech Companies, and Others), and Region 2024-2032Pharmaceutical_LifeSciense Market



Abstract


Summary

The global medical thawing system market size reached US$ 205.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 372.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.63% during 2024-2032. The increasing prevalence of chronic diseases, the rising demand for regenerative and personalized medicines, and ongoing technological advancements represent some of the key factors driving the market. A medical thawing system is used in healthcare facilities to thaw frozen biological specimens such as blood products, vaccines, and tissue samples safely and quickly. It employs a controlled process of heating and agitating the frozen specimen in a water bath, allowing it to thaw evenly without causing any damage to the sample. In addition to this, they help minimize the risk of contamination, ensure accurate and reliable test results, and reduce the risk of injury to healthcare workers handling frozen specimens. The medical thawing system meets strict regulatory standards for handling biological materials and is essential in ensuring the quality and efficacy of the thawed specimen. As a result, it is widely employed across various healthcare facilities as a reliable, efficient, and standardized device for ensuring the quality and efficacy of biological samples used in patient care and research. Medical Thawing System Market Trends: The rising number of individuals suffering from chronic diseases and viral and bacterial infections is one of the primary factors driving the market growth. In line with this, the growing inclination toward organ transplantation and an increase in organ donors combined with the surging demand for blood transfusions is creating a favorable outlook for the market. In addition to this, the expanding demand for regenerative medicine is fuelling the need for safe and efficient thawing of stem cells, tissues, and other biological samples, which, in turn, is contributing to the market growth. Moreover, innovative technological advancements, such as the integration of automation and robotics technology to enhance the efficiency and accuracy of thawing systems, are presenting remunerative growth opportunities for the market. Furthermore, the outbreak of the COVID-19 virus has impelled the collection of tissue specimens for researching the biological impact of the infection and identifying new therapeutic interventions and prevention strategies, which is positively impacting the market growth. Other factors, such as the rising geriatric population, increasing healthcare expenditure, growing number of people participating in blood donation campaigns, the escalating demand for personalized medicines, and extensive investments in research and development (R&D) projects to develop effective therapies for treating rare diseases, are strengthening the market growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global medical thawing system market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, sample type and end user. Product Type Insights: Manual Automated The report has provided a detailed breakup and analysis of the medical thawing system market based on the product type. This includes manual and automated. According to the report, the manual represented the largest segment. Sample Type Insights: Blood Plasma Stem Cells Whole Blood Platelets Embryo Ovum Semen A detailed breakup and analysis of the medical thawing system market based on the sample type has also been provided in the report. This includes blood (plasma, stem cells, whole blood and platelets), embryo, ovum and semen. According to the report, blood accounted for the largest market share. End User Insights: Blood Banks Hospitals Tissue Banks Pharmaceutical and Biotech Companies Others The report has provided a detailed breakup and analysis of the medical thawing system market based on the end-user. This includes blood banks, hospitals, tissue banks, pharmaceutical and biotech companies, and others. According to the report, blood banks represented the largest segment. Regional Insights: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for medical thawing system. Some of the factors driving the North America medical thawing system market included the growing prevalence of life-threatening chronic diseases, the increasing adoption of regenerative and personalized medicines, and the rising geriatric population. Competitive Landscape: The report has also provided a comprehensive analysis of the competitive landscape in the global medical thawing system market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report. Key Questions Answered in This Report 1. What was the size of the global medical thawing system market in 2023? 2. What is the expected growth rate of the global medical thawing system market during 2024-2032? 3. What are the key factors driving the global medical thawing system market? 4. What has been the impact of COVID-19 on the global medical thawing system market? 5. What is the breakup of the global medical thawing system market based on the product type? 6. What is the breakup of the global medical thawing system market based on the sample type? 7. What is the breakup of the global medical thawing system market based on the end user? 8. What are the key regions in the global medical thawing system market? 9. Who are the key players/companies in the global medical thawing system market?

Table of Contents

  • 1 Preface

  • 2 Scope and Methodology

    • 2.1 Objectives of the Study
    • 2.2 Stakeholders
    • 2.3 Data Sources
      • 2.3.1 Primary Sources
      • 2.3.2 Secondary Sources
    • 2.4 Market Estimation
      • 2.4.1 Bottom-Up Approach
      • 2.4.2 Top-Down Approach
    • 2.5 Forecasting Methodology
  • 3 Executive Summary

  • 4 Introduction

    • 4.1 Overview
    • 4.2 Key Industry Trends
  • 5 Global Medical Thawing System Market

    • 5.1 Market Overview
    • 5.2 Market Performance
    • 5.3 Impact of COVID-19
    • 5.4 Market Forecast
  • 6 Market Breakup by Product Type

    • 6.1 Manual
      • 6.1.1 Market Trends
      • 6.1.2 Market Forecast
    • 6.2 Automated
      • 6.2.1 Market Trends
      • 6.2.2 Market Forecast
  • 7 Market Breakup by Sample Type

    • 7.1 Blood
      • 7.1.1 Market Trends
      • 7.1.2 Key Segments
        • 7.1.2.1 Plasma
        • 7.1.2.2 Stem Cells
        • 7.1.2.3 Whole Blood
        • 7.1.2.4 Platelets
      • 7.1.3 Market Forecast
    • 7.2 Embryo
      • 7.2.1 Market Trends
      • 7.2.2 Market Forecast
    • 7.3 Ovum
      • 7.3.1 Market Trends
      • 7.3.2 Market Forecast
    • 7.4 Semen
      • 7.4.1 Market Trends
      • 7.4.2 Market Forecast
  • 8 Market Breakup by End User

    • 8.1 Blood Banks
      • 8.1.1 Market Trends
      • 8.1.2 Market Forecast
    • 8.2 Hospitals
      • 8.2.1 Market Trends
      • 8.2.2 Market Forecast
    • 8.3 Tissue Banks
      • 8.3.1 Market Trends
      • 8.3.2 Market Forecast
    • 8.4 Pharmaceutical and Biotech Companies
      • 8.4.1 Market Trends
      • 8.4.2 Market Forecast
    • 8.5 Others
      • 8.5.1 Market Trends
      • 8.5.2 Market Forecast
  • 9 Market Breakup by Region

    • 9.1 North America
      • 9.1.1 United States
        • 9.1.1.1 Market Trends
        • 9.1.1.2 Market Forecast
      • 9.1.2 Canada
        • 9.1.2.1 Market Trends
        • 9.1.2.2 Market Forecast
    • 9.2 Asia-Pacific
      • 9.2.1 China
        • 9.2.1.1 Market Trends
        • 9.2.1.2 Market Forecast
      • 9.2.2 Japan
        • 9.2.2.1 Market Trends
        • 9.2.2.2 Market Forecast
      • 9.2.3 India
        • 9.2.3.1 Market Trends
        • 9.2.3.2 Market Forecast
      • 9.2.4 South Korea
        • 9.2.4.1 Market Trends
        • 9.2.4.2 Market Forecast
      • 9.2.5 Australia
        • 9.2.5.1 Market Trends
        • 9.2.5.2 Market Forecast
      • 9.2.6 Indonesia
        • 9.2.6.1 Market Trends
        • 9.2.6.2 Market Forecast
      • 9.2.7 Others
        • 9.2.7.1 Market Trends
        • 9.2.7.2 Market Forecast
    • 9.3 Europe
      • 9.3.1 Germany
        • 9.3.1.1 Market Trends
        • 9.3.1.2 Market Forecast
      • 9.3.2 France
        • 9.3.2.1 Market Trends
        • 9.3.2.2 Market Forecast
      • 9.3.3 United Kingdom
        • 9.3.3.1 Market Trends
        • 9.3.3.2 Market Forecast
      • 9.3.4 Italy
        • 9.3.4.1 Market Trends
        • 9.3.4.2 Market Forecast
      • 9.3.5 Spain
        • 9.3.5.1 Market Trends
        • 9.3.5.2 Market Forecast
      • 9.3.6 Russia
        • 9.3.6.1 Market Trends
        • 9.3.6.2 Market Forecast
      • 9.3.7 Others
        • 9.3.7.1 Market Trends
        • 9.3.7.2 Market Forecast
    • 9.4 Latin America
      • 9.4.1 Brazil
        • 9.4.1.1 Market Trends
        • 9.4.1.2 Market Forecast
      • 9.4.2 Mexico
        • 9.4.2.1 Market Trends
        • 9.4.2.2 Market Forecast
      • 9.4.3 Others
        • 9.4.3.1 Market Trends
        • 9.4.3.2 Market Forecast
    • 9.5 Middle East and Africa
      • 9.5.1 Market Trends
      • 9.5.2 Market Breakup by Country
      • 9.5.3 Market Forecast
  • 10 SWOT Analysis

    • 10.1 Overview
    • 10.2 Strengths
    • 10.3 Weaknesses
    • 10.4 Opportunities
    • 10.5 Threats
  • 11 Value Chain Analysis

  • 12 Porters Five Forces Analysis

    • 12.1 Overview
    • 12.2 Bargaining Power of Buyers
    • 12.3 Bargaining Power of Suppliers
    • 12.4 Degree of Competition
    • 12.5 Threat of New Entrants
    • 12.6 Threat of Substitutes
  • 13 Price Analysis

  • 14 Competitive Landscape

    • 14.1 Market Structure
    • 14.2 Key Players
    • 14.3 Profiles of Key Players
      • 14.3.1 Barkey GmbH & Co. KG
        • 14.3.1.1 Company Overview
        • 14.3.1.2 Product Portfolio
      • 14.3.2 Biolife Solutions Inc
        • 14.3.2.1 Company Overview
        • 14.3.2.2 Product Portfolio
        • 14.3.2.3 Financials
      • 14.3.3 Boekel Scientific
        • 14.3.3.1 Company Overview
        • 14.3.3.2 Product Portfolio
      • 14.3.4 Cardinal Health Inc
        • 14.3.4.1 Company Overview
        • 14.3.4.2 Product Portfolio
        • 14.3.4.3 Financials
        • 14.3.4.4 SWOT Analysis
      • 14.3.5 General Electric Company
        • 14.3.5.1 Company Overview
        • 14.3.5.2 Product Portfolio
        • 14.3.5.3 Financials
        • 14.3.5.4 SWOT Analysis
      • 14.3.6 Helmer Scientific Inc
        • 14.3.6.1 Company Overview
        • 14.3.6.2 Product Portfolio
      • 14.3.7 Hospicare Systems
        • 14.3.7.1 Company Overview
        • 14.3.7.2 Product Portfolio
      • 14.3.8 labcold Limited
        • 14.3.8.1 Company Overview
        • 14.3.8.2 Product Portfolio
      • 14.3.9 MMS Medical and Laboratory Supplies
        • 14.3.9.1 Company Overview
        • 14.3.9.2 Product Portfolio
      • 14.3.10 Sarstedt AG & Co. KG
        • 14.3.10.1 Company Overview
        • 14.3.10.2 Product Portfolio
      • 14.3.11 Sartorius AG
        • 14.3.11.1 Company Overview
        • 14.3.11.2 Product Portfolio
        • 14.3.11.3 Financials
        • 14.3.11.4 SWOT Analysis
      • 14.3.12 Terumo Penpol Private Limited (Terumo Corporation)
        • 14.3.12.1 Company Overview
        • 14.3.12.2 Product Portfolio
      • 14.3.13 Thermo Fisher Scientific Inc
        • 14.3.13.1 Company Overview
        • 14.3.13.2 Product Portfolio
        • 14.3.13.3 Financials
        • 14.3.13.4 SWOT Analysis
USD 5,399 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.